|
|
Volumn 59, Issue 3, 2003, Pages 261-262
|
|
Signal that reboxetine use is linked with symptoms of peripheral ischaemia (Raynaud's syndrome)
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FLUVOXAMINE;
NEFAZODONE;
NORFLUOXETINE;
REBOXETINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
DRUG DOSE REDUCTION;
DRUG METABOLISM;
DRUG WITHDRAWAL;
HUMAN;
ISCHEMIA;
LETTER;
PRIORITY JOURNAL;
RAYNAUD PHENOMENON;
SIGNAL TRANSDUCTION;
VASCULAR DISEASE;
VASOCONSTRICTION;
ADRENERGIC UPTAKE INHIBITORS;
FEMALE;
FINGERS;
HUMANS;
ISCHEMIA;
MALE;
MORPHOLINES;
RAYNAUD DISEASE;
|
|
EID: 0041662074
PISSN: 00316970
EISSN: None
Source Type: Journal
DOI: 10.1007/s00228-003-0611-5 Document Type: Letter |
|
Times cited : (2)
|
|
References (3)
|
